← Back to Screener
Carlsmed, Inc. Common Stock (CARL)
Price$11.10
Growth ScoreF
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-19.31%
Price vs S&P 500 (4W)15.49%
VGM Score18.86
Market Capitalization$310.45M
All Metrics
Book Value / Share (Quarterly)$3.72
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.14
Price vs S&P 500 (YTD)-18.46%
Gross Margin (TTM)75.31%
Net Profit Margin (TTM)-58.67%
EPS (TTM)$-1.19
10-Day Avg Trading Volume0.32M
EPS Excl Extra (TTM)$-1.19
EPS (Annual)$-4.17
ROI (Annual)-51.89%
Gross Margin (Annual)75.31%
Cash / Share (Quarterly)$4.13
Revenue Growth QoQ (YoY)-44.17%
ROA (Last FY)-45.55%
EBITD / Share (TTM)$-1.20
Operating Margin (TTM)-60.53%
Cash Flow / Share (Annual)$-2.23
P/B Ratio3.14x
P/B Ratio (Quarterly)3.32x
Net Income / Employee (Annual)$-466,700
Net Interest Coverage (TTM)-122.11x
ROA (TTM)-31.51%
EPS Incl Extra (Annual)$-4.17
Current Ratio (Annual)8.87x
Quick Ratio (Quarterly)8.49x
3-Month Avg Trading Volume0.15M
Revenue / Employee (TTM)$397,700
P/S Ratio (Annual)6.15x
Asset Turnover (Annual)0.39x
52-Week High$17.19
EPS Excl Extra (Annual)$-4.17
26-Week Price Return-3.38%
Quick Ratio (Annual)8.49x
13-Week Price Return-21.57%
Total Debt / Equity (Annual)0.16x
Current Ratio (Quarterly)8.87x
Enterprise Value$240.00M
Asset Turnover (TTM)0.54x
Revenue / Employee (Annual)$397,700
Pretax Margin (Annual)-117.34%
Cash / Share (Annual)$4.13
3-Month Return Std Dev71.17%
Net Income / Employee (TTM)$-233,300
ROE (Last FY)-59.95%
EPS Basic Excl Extra (Annual)$-4.17
Total Debt / Equity (Quarterly)0.16x
EPS Incl Extra (TTM)$-1.19
ROI (TTM)-36.54%
P/S Ratio (TTM)6.15x
Revenue / Share (Annual)$3.55
Year-to-Date Return-7.53%
5-Day Price Return-5.70%
EPS Normalized (Annual)$-4.17
Net Profit Margin (Annual)-117.34%
Month-to-Date Return28.46%
EBITD / Share (Annual)$-4.28
Operating Margin (Annual)-121.06%
LT Debt / Equity (Annual)0.16x
LT Debt / Equity (Quarterly)0.16x
EPS Basic Excl Extra (TTM)$-1.19
P/B Ratio (Annual)3.32x
Pretax Margin (TTM)-58.67%
Book Value / Share (Annual)$3.72
Price vs S&P 500 (13W)-31.31%
Beta2.73x
Revenue / Share (TTM)$1.89
ROE (TTM)-45.04%
52-Week Low$8.50
gGradeF
mGradeD
vgmGradeF
Show chart for
Earnings Surprise History
Q1 26-0.32est. -0.40
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.27
4.27
4.27
4.27
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CARLCarlsmed, Inc. Common Stock | — | F | D | $11.10 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Carlsmed Inc is a commercial-stage medical technology company developing AI-enabled personalized solutions for spine surgery. Its Aprevo platform delivers customized surgical planning and implants for lumbar and cervical fusion procedures, marketed to hospitals and ambulatory surgical centers.